US FTC suspends problem to dam Amgen’s $27.8 billion deal for Horizon Therapeutics By Reuters Stock US FTC suspends problem to dam Amgen’s $27.8 billion deal for Horizon Therapeutics By Reuters August 26, 2023 Read More